06/09/2025 4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 7:53 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2025 2:10 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025 1:57 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) Ayrton Capital LLC (Filed by)
| Form SCHEDULE 13G | |
04/09/2025 7:31 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2025 11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
02/14/2025 4:21 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025 4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/11/2025 3:53 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
02/06/2025 9:04 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
02/03/2025 3:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for SXTPW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
01/30/2025 4:30 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2025 7:28 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
01/24/2025 3:51 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) MILLER TYRONE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2025 3:52 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 3:58 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) MILLER TYRONE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 4:00 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2025 3:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 7:35 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 4:07 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 5:14 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 12:44 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 3:01 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) Knight Therapeutics Inc (Filed by)
| Form SC 13G/A | |
11/06/2024 4:26 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 2:46 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form DEF 14A | |
10/08/2024 7:17 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 9:56 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form PRE 14A | |
09/30/2024 11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
09/19/2024 3:30 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
09/11/2024 3:46 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 2:59 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 9:29 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024 11:03 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 3:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 12:21 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
07/24/2024 4:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
07/22/2024 10:23 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
07/18/2024 11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
07/16/2024 4:28 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 4:02 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/09/2024 2:37 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Gold is soaring. Here’s how to get paid from it (Ad) Gold just broke through $3,300…
And while the headlines shout about price targets, something even more powerful is happening behind the scenes…
Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge.
No trading gold futures. No mining stocks. No vaults.
Just a simple fund delivering monthly payouts — like clockwork. Click here to discover the income ETF behind it all. |
06/27/2024 4:06 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2024 4:26 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |